所有图片(1)
About This Item
经验公式（希尔记法）:
C5H10O4
CAS号:
分子量:
134.13
MDL號碼:
分類程式碼代碼:
12352201
PubChem物質ID:
NACRES:
NA.25
推荐产品
化驗
≥97.0% (TLC)
形狀
powder
光學活性
[α]/D 54.0±2.0°, 24 hr, c = 1 in H2O
儲存溫度
2-8°C
SMILES 字串
O=CC[C@@H](O)[C@@H](O)CO
InChI
1S/C5H10O4/c6-2-1-4(8)5(9)3-7/h2,4-5,7-9H,1,3H2/t4-,5+/m1/s1
InChI 密鑰
ASJSAQIRZKANQN-UHNVWZDZSA-N
正在寻找类似产品? 访问 产品对比指南
生化／生理作用
Inhibitor of enzymes and valuable building block for synthesis
其他說明
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Masao Shiozaki et al.
Carbohydrate research, 370, 46-66 (2013-03-05)
KRN7000 is one of the α-galactosylceramides, which has a 2-hexacosanoylamino-3,4-dihydroxyoctadecyl group. This compound, known as a ligand for the activation of CD1d mediated invariant natural killer T cells (iNKT cells) which release both T helper 1 (Th1) cytokines such as
Ryuji Ikeda et al.
Biochemical and biophysical research communications, 291(4), 806-812 (2002-02-28)
An angiogenic factor, platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP), stimulates the chemotaxis of endothelial cells and confers resistance to apoptosis induced by hypoxia. 2-deoxy-D-ribose, a degradation product of thymidine generated by TP enzymatic activity partially prevented hypoxia-induced apoptosis. 2-Deoxy-D-ribose
Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.
Pauline Peltier-Pain et al.
ChemMedChem, 6(8), 1347-1350 (2011-06-30)
Aqeel Ahmed et al.
Journal of the American Chemical Society, 128(44), 14224-14225 (2006-11-02)
The reaction of 70 unprotected, diversely functionalized free reducing sugars with methoxyamine-appended colchicine led to the production of a 58-member glycorandomized library. High-throughput cytotoxicity assays revealed glycosylation to modulate specificity and potency. Library members were also identified which, unlike the
Serkan Dikici et al.
Microvascular research, 131, 104035-104035 (2020-07-01)
Delayed neovascularisation of tissue-engineered (TE) complex constructs is a major challenge that causes their failure post-implantation. Although significant progress has been made in the field of angiogenesis, ensuring rapid neovascularisation still remains a challenge. The use of pro-angiogenic agents is
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门